Anti-DLL3 antibody drug conjugates for treating cancer
US-10137204-B2 · Nov 27, 2018 · US
Human Necessities
Human Necessities · Cooperative Patent Classification (CPC)
Agriculture, food, personal care, health, and life sciences.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | A61K47/48723 |
| Official title | — |
| Display label | Human Necessities (mapped technology topic) |
| Total patents | 54 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity appears to be declining based on the most recent years.
| Year | Patents |
|---|---|
| 2015 | 10 |
| 2016 | 16 |
| 2017 | 20 |
| 2018 | 8 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Chimeric small molecules for the recruitment of antibodies to cancer cells
US-10066026-B2 · Sep 4, 2018 · US
Targeting immunotherapy for amyloidosis
US-10046050-B2 · Aug 14, 2018 · US
Pyrrolobenzodiazepines and conjugates thereof
US-9889207-B2 · Feb 13, 2018 · US
Methods of delivering DLL3 antibody drug conjugates
US-9878053-B2 · Jan 30, 2018 · US
Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use thereof
US-9867886-B2 · Jan 16, 2018 · US
Kits containing DLL3 antibody drug conjugates
US-9861708-B2 · Jan 9, 2018 · US
Anti-DLL3 antibody drug conjugates
US-9855343-B2 · Jan 2, 2018 · US
Anti-DLL3 antibody drug conjugates for treating cancer
US-9775916-B1 · Oct 3, 2017 · US
Enhanced regulatory t cells targeted to sites of inflammation with chimeric antigen receptors and expressing factors that enhance viability of pancreatic cells
US-2017274095-A1 · Sep 28, 2017 · US
Dll3 modulators and methods of use
US-2017274094-A1 · Sep 28, 2017 · US
Anti-DLL3 antibody drug conjugates
US-9770518-B1 · Sep 26, 2017 · US
Conjugation methods
US-9771432-B2 · Sep 26, 2017 · US
Methods of making dll3 antibody drug conjugates
US-2017266314-A1 · Sep 21, 2017 · US
Methods of delivering dll3 antibody drug conjugates
US-2017266313-A1 · Sep 21, 2017 · US
Anti-dll3 antibody drug conjugates
US-2017266312-A1 · Sep 21, 2017 · US
Anti-dll3 antibody drug conjugates for treating cancer
US-2017266315-A1 · Sep 21, 2017 · US
Methods of making DLL3 antibody drug conjugates
US-9764042-B1 · Sep 19, 2017 · US
Modulators and methods of use
US-9765136-B2 · Sep 19, 2017 · US
Crosslinked polymer nano-assemblies and uses thereof
US-2017216450-A1 · Aug 3, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC A61K47/48723?
- CPC A61K47/48723 is the Cooperative Patent Classification code for “Human Necessities.”
- How many patents are filed under CPC A61K47/48723 (Human Necessities)?
- Our database includes 54 publications tagged with this CPC code.
- Is patent activity under CPC A61K47/48723 growing?
- Publication counts under this code: 20 in 2017 vs 8 in 2018 (latest complete years).